Delivery Order SPE2DB22D2007-SPE2DB25FJ3VH
- Not listed
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Afinitor 5 mg tablets in unit dose packaging (28-count), with a contract ceiling value of $38,092.75 and a firm fixed-price structure. This delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $13,017.66 to AmerisourceBergen Drug Corp for Afinitor 5 mg tablets (28-count unit dose packaging) on November 7, 2025, with completion scheduled for December 2, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award falls under the company's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 28 units of Afinitor 5 mg tablets in unit dose packaging, valued at $37,057.56 under a firm fixed price contract type. The award, issued on October 27, 2025, is scheduled for completion by November 18, 2025, with performance taking place at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This is a competitively awarded non-set-aside contract, reflecting the company's established capability to...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Afinitor Disperz 3 mg tablets in quantities of 28 units. This competitively awarded, non-set-aside contract carries a ceiling value of $47,663.84 under firm fixed pricing terms, with an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of Afinitor Disperz 3 mg tablets. The contract has a ceiling value of $20,344.14 and an ultimate completion date of October 11, 2024. It is a firm-fixed-price contract type. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of prescription medications, medical supplies, and equipment to various...
- This is a $20,805.32 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is for the supply of Afinitor 10 mg tablets, a pharmaceutical product used in the treatment of certain medical conditions. The award has an ultimate completion date of September 13, 2024 and does not include a set-aside designation. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $10,000 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 2.5 mg tablets of AFINITOR to treat for a 28-day period. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, beginning in mid-September and concluding in early October of this year. The prime contractor, Amerisourcebergen Drug Corporation, is a division of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The firm fixed price contract is for the supply of Afinitor 10 mg tablets, with a potential value of $20,805.32. The contract is to be completed by February 1, 2024, with the award date being January 10, 2024. No set-aside was used for this award. Amerisourcebergen Drug Corp has previously...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,600.94, is a Firm Fixed Price Delivery Order for the supply of the drug Afinitor 2.5 mg tablet, with a completion date of May 2, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,891.25 Firm Fixed Price Delivery Order contract is for the supply of AFINITOR 2.5 MG TABLET UD 28S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3VHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Afinitor 10 mg tablets in unit dose packages of 28 count. This competitively awarded, firm fixed-price contract carries a ceiling value of $12,360.81 and is scheduled for completion by September 2, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. As a delivery order, this contract is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion pharmaceutical prime vendor agreement valued through December 2026 that supports military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of federal contracts involving brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for Afinitor, a specialty oncology medication, reflects the company's role in supplying specialized pharmaceuticals through the DLA's Medical Supply Chain to support military and veteran healthcare requirements. No set-aside designation was utilized for this competitive award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 8/11/25 |